FIGURE 1 WT CD2 TG CD25 CONTROL IL-2 CD3/CD28 CD3/CD28+IL

Slides:



Advertisements
Similar presentations
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
Advertisements

 decimals/cc-7th-fracs-to-decimals/v/converting-fractions-to-decimals-example.
FSCCD40 mediumFluCL %82 %97 % SSC FSC GEN2.2 cells B mediumFluCL097CpG ACpG B GEN2.2 GENshTLR7 % CD40 positive cells TLR7TLR9 0.0.
GFP-RV IFN/GFP-RV GFP-RV IFN/GFP-RV A B CD 8 C CD 8 GFP GFP GFP-RV
Figure 6. DIM inhibits the differentiation of Foxp3+ Tregs induced by tolerogenic DCs. Naïve CD4+CD62+ helper T cells (2×105) were cultured with 4×104.
Fig. 2. Comparison of the Th1/Th2 ratio and the percentages of Th1 and Th2 cells between normal and allergic individuals. (A) The Th1/Th2 ratio observed.
Volume 132, Issue 3, Pages (March 2007)
500 mg total protein /mL S-CM 250 mg total protein /mL S-CM
Volume 7, Issue 5, Pages (November 1997)
% of Suppression a-TGFb (ug/ml) Tr/Tresp 1:1 1:4
Volume 27, Issue 4, Pages (October 2007)
by Jacob Rachmilewitz, Gregory J
by Rui Zhang, Jeffrey D. Lifson, and Claire Chougnet
Volume 138, Issue 2, Pages e2 (February 2010)
Identification of CD3+CD4−CD8− T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD)  Fumi Miyagawa,
Volume 81, Issue 2, Pages (January 2012)
Tatsukuni Ohno, Yuta Kondo, Chenyang Zhang, Siwen Kang, Miyuki Azuma 
Cytokine and chemokine expression of flucloxacillin-specific T cell clones (TCC) of patient P1. Cytokine and chemokine expression of flucloxacillin-specific.
Volume 130, Issue 2, Pages (February 2006)
Proteins Peptides DnaK Peptides + DnaK
Volume 143, Issue 5, Pages e4 (November 2012)
IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor  Eran Elinav, Nitzan Adam,
Volume 132, Issue 1, Pages (January 2007)
FR255734, a Humanized, Fc-Silent, Anti-CD28 Antibody, Improves Psoriasis in the SCID Mouse-Psoriasis Xenograft Model  Siba P. Raychaudhuri, Smriti Kundu-Raychaudhuri,
H31m1-PDL1 cells form progressively growing tumors in WT mice.
IL-6 is dispensable for the suppressive activity of MDSC on primary CD4+ T-cell activation. IL-6 is dispensable for the suppressive activity of MDSC on.
Volume 140, Issue 7, Pages (June 2011)
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
Supplementary Figure 1 FSC-A SSC-A HC UC CD
Peptide ID# Pulsed to T2-A24 Cells
IL-18, but Not IL-12, Induces Production of IFN-γ in the Immunosuppressive Environment of HPV16 E7 Transgenic Hyperplastic Skin  Christina Gosmann, Ian.
Volume 34, Issue 3, Pages (March 2011)
Volume 36, Issue 2, Pages (February 2012)
Stanford L Peng, Andrea J Gerth, Ann M Ranger, Laurie H Glimcher 
Supplementary Figure 1 a b c i ii iii i ii iii i ii iii
Volume 29, Issue 1, Pages (July 2008)
Phlebotomus papatasi Yellow-Related and Apyrase Salivary Proteins Are Candidates for Vaccination against Human Cutaneous Leishmaniasis  Aymen Tlili, Soumaya.
The Notch Ligands Jagged2, Delta1, and Delta4 Induce Differentiation and Expansion of Functional Human NK Cells from CD34+ Cord Blood Hematopoietic Progenitor.
STING activation induces inhibition of the mTORC1 pathway.
The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells  Juha Punnonen, MD, PhD, Hans Yssel, PhD,
mTORC1 signaling is required for STING-mediated type I IFN responses.
Molecular mechanism of STING-mediated inhibition of the mTORC1 pathway
Volume 123, Issue 5, Pages (November 2002)
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 81, Issue 2, Pages (January 2012)
Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis  Margarete Niebuhr, MD, Helena Scharonow, MS, Merle Gathmann,
Influence of pro-inflammatory (IL-1α, IL-6, TNF-α, IFN-γ) and anti-inflammatory (IL-4) cytokines on chondrocyte function  A.J Schuerwegh, M.D., Ph.D.,
by Defne Bayik, Debra Tross, Lydia A
A n.s. WT 4-1BB-/- B n.s. WT 4-1BB-/-
Interleukin-7–Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population  Paolo Sportoletti, Beatrice Del Papa, Mariangela De Ioanni, Lorenzo.
Blimp-1 expression is enhanced in both si-tolerant T cells and CD3/CD155-ligated T cells. Blimp-1 expression is enhanced in both si-tolerant T cells and.
Dimethylfumarate Induces Immunosuppression via Glutathione Depletion and Subsequent Induction of Heme Oxygenase 1  Joachim C.U. Lehmann, Joanna J. Listopad,
Volume 11, Issue 3, Pages (September 1999)
Volume 131, Issue 6, Pages (December 2006)
The mucosal environment regulates CD160 expression on IELs
David M. Essayan, MD, Charity C
IRF4 expression is modulated by the signaling of IL-2 family cytokines
Harald Renz, MD, Chaya Brodie, PhD, Katherine Bradley, BS, Donald Y. M
PD-1 blockade enhances T-cell function.
Impairment of T-regulatory cells in cord blood of atopic mothers
Interleukin-1 blockade effects interferon (IFN)-γ production by multiple cell types. a) Gating strategy for flow cytometry: CD56+ natural killer (NK) cells.
TSG-6 suppressed APC activation in vitro and in vivo.
Members of IL-1 family of cytokines favor the generation of IL-3–secreting CD4+ T cells in vitro. Members of IL-1 family of cytokines favor the generation.
Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-γ–producing cells  Francesca.
Vaginal CD11c+ DCs from IL-17A−/− mice are impaired in potentiating Th17 responses because of diminished IL-1β production. Vaginal CD11c+ DCs from IL-17A−/−
Figure 4. EC-18 dephosphorylated activated STAT6
Fig. 2. Effect of activated vitamin D on immune cells
LSECtin, expressed by B16 cells, inhibits the tumor-specific immune responses both in vivo and in vitro. LSECtin, expressed by B16 cells, inhibits the.
Presentation transcript:

FIGURE 1 WT CD2 TG CD25 CONTROL IL-2 CD3/CD28 CD3/CD28+IL-2 74.3 9.9 74.3 9.9 89.4 6.8 45.4 52 50.7 47.9 WT TG CD2 84.1 9.1 85.4 10.6 42.2 56.1 41.5 56 CD25 FIGURE 1

FIGURE 2 WT TG Thymidine Uptake (cpm) IL-2 Control CD3/CD28 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 Control CD3/CD28 IL-2 IL-2 + CD3/CD28 WT TG Thymidine Uptake (cpm) FIGURE 2

FIGURE 3 WT TG ** * Unstimulated Anti-CD3/CD28 IL-10 (ng/mL) 0,5 1 1,5 2 2,5 200 400 600 800 1000 1200 20 40 60 80 100 120 10 30 50 70 0,1 0,2 0,3 0,4 0,6 ** * IL-10 (ng/mL) IL-4 (pg/mL) IL-13 (pg/mL) IFN- (ng/mL) IL-2 (ng/mL) Unstimulated Anti-CD3/CD28 FIGURE 3 WT TG

* FIGURE 4 IL-2 + anti-CD3/28 IL-2 anti-CD3/28 Unstimulated CD4+ CD8+ 10 20 30 40 50 60 anti-CD3/28 Unstimulated CD4+ CD8+ 70 FIGURE 4 PERCENTAGE OF CELL NUMBER WT TG

FIGURE 5 WT TG WT TG T CD4 CD8 10 20 30 40 50 60 70 % CELL NUMBER * 80 10 20 30 40 50 60 70 T CD4 CD8 % CELL NUMBER * 80 100 120 140 CELL NUMBER WT TG WT TG FIGURE 5